Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

7.84USD
10 Dec 2018
Change (% chg)

$-0.03 (-0.38%)
Prev Close
$7.87
Open
$7.96
Day's High
$8.14
Day's Low
$7.80
Volume
19,115
Avg. Vol
44,542
52-wk High
$12.00
52-wk Low
$4.77

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.36 December 11 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 4 1.98 5.50 0.00 0.00
Quarter Ending Mar-19 3 0.50 1.50 0.00 --
Year Ending Dec-18 4 4.49 6.30 3.89 1.95
Year Ending Dec-19 5 3.23 6.40 0.00 6.01
Earnings (per share)
Quarter Ending Dec-18 5 -0.36 -0.15 -0.52 -0.51
Quarter Ending Mar-19 3 -0.62 -0.46 -0.88 --
Year Ending Dec-18 5 -1.87 -1.59 -2.02 -2.13
Year Ending Dec-19 5 -2.39 -1.60 -3.51 -2.59

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 1.08 0.00 1.08 100.00
Quarter Ending Jun-18 1.63 2.38 0.74 45.50
Quarter Ending Mar-18 1.60 1.51 0.09 5.63
Quarter Ending Dec-17 1.16 1.48 0.32 27.34
Quarter Ending Sep-17 1.09 1.26 0.17 15.95

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 1.98 1.98 0.85 0.98 0.00
Quarter Ending Mar-19 0.50 0.50 0.75 0.75 --
Year Ending Dec-18 4.49 4.49 5.29 5.29 1.95
Year Ending Dec-19 3.23 3.23 3.15 2.63 6.01

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 2 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 1
Year Ending Dec-19 0 0 1 0
Earnings